SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (149)10/21/1999 4:12:00 PM
From: jeffbas  Read Replies (1) | Respond to of 438
 
Not only does this come with the Cell Genesys deal to GZMO, but if you listened carefully to the conference call, Gail Maderis said that the results reported by JH were with only a first generation vaccine approach! Apparently a second generation approach using "adenovirus" should be even superior.



To: gao seng who wrote (149)10/23/1999 4:40:00 PM
From: LLCF  Read Replies (1) | Respond to of 438
 
<Anti-Metastatic Gene Therapy Turns On Immune System>

Is this in the clinic???

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News